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Abstract 
Tumor stiffening, stemming from aberrant production and organization of extracellular matrix (ECM), 
has been considered a predictive marker of tumor malignancy, non-invasively assessed by ultrasound 
shear wave elastography (SWE). Being more than a passive marker, tumor stiffening restricts the 
delivery of diagnostic and therapeutic agents to the tumor and per se could modulate cellular 
mechano-signaling, tissue inflammation and tumor progression. Current strategies to modify the tumor 
extracellular matrix are based on ECM-targeting chemical agents but also showed deleterious systemic 
effects. 
On-demand excitable nanomaterials have shown their ability to perturb the tumor microenvironment 
in a spatiotemporal-controlled manner and synergistically with chemotherapy. Here, we investigated 
the evolution of tumor stiffness as well as tumor integrity and progression, under the effect of mild 
hyperthermia and thermal ablation generated by light-exposed multi-walled carbon nanotubes 
(MWCNTs) in an epidermoid carcinoma mouse xenograft. SWE was used for real-time mapping of the 
tumor stiffness, both during the two near infrared irradiation sessions and over the days after the 
treatment. We observed a transient and reversible stiffening of the tumor tissue during laser irradiation, 
which was lowered at the second session of mild hyperthermia or photoablation. In contrast, over the 
days following photothermal treatment, the treated tumors exhibited a significant softening together 
with volume reduction, whereas non-treated growing tumors showed an increase of tumor rigidity. The 
organization of the collagen matrix and the distribution of CNTs revealed a spatio-temporal correlation 
between the presence of nanoheaters and the damages on collagen and cells. This study highlights 
nanohyperthermia as a promising adjuvant strategy to reverse tumor stiffening and normalize the 
mechanical tumor environment. 
Key words: photothermal therapy, carbon nanotubes, cancer, elastography, tumor microenvironment. 
Introduction 
Tissue mechanics is modified in tumor 
progression at both cell- and tissue-level. Current 
clinical techniques (elastography) interrogate tissue 
stiffness as a passive feature to detect cancer. In 
particular, ultrasound shear wave elastography 
(SWE) as well as magnetic resonance elastography 
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yield quantitative information capable of discerning 
benign versus malignant lesions, the latter being 
characterized by increased stiffness.1, 2 Experimental 
evidences also suggest that tissue mechanics, per se, is 
a key modulator of tumor progression and clinical 
outcome. Analyses of human breast cancer of 
increasingly aggressive subtype revealed that cancer 
transformation is accompanied by a progressive 
increase in collagen deposition and a linearization and 
thickening of interstitial collagen. At the invasive 
region of the tumor, the stroma is the most 
heterogeneous and the stiffest while the number of 
infiltrating tumor-activated macrophages and TGF 
beta signaling are the highest. These observations 
suggest a tight relationship between extracellular 
matrix (ECM) remodelling and stiffening, cellular 
mechanosignaling, tissue inflammation and tumor 
aggression.3 A causal relationship between ECM 
stiffening and the most aggressive cancer subtypes 
could provide a set of prognostic biomarkers. 
Although molecular mechanisms by which altered 
mechanics regulate tumor behavior remain unclear, a 
number of mechanosignaling pathways have been 
recently demonstrated. For example, inducing 
collagen crosslinking by lysyl oxidase stiffens the 
ECM, promotes focal adhesion by forcing integrin 
clustering, enhances PI3 kinase activity and induces 
the invasion of a premalignant epithelium.4 Increased 
matrix stiffness also modulates the expression of 
tumor suppressor genes through a microRNA 
(miRNA)–mediated transcriptional circuit. In patient 
samples, the abundance of miRNA-18a was higher in 
breast tumor tissue than in normal tissue, and 
correlated with tumor stiffness, aggression and poor 
survival.5 Such new mechanism orchestrated by a 
microRNA circuit is shown to mediate the physical 
effects of the microenvironment on tumor cell 
progression.6  
The tumor microenvironment also mediates the 
response of solid tumors to chemo- and 
nanoparticle-based therapies. Aberrantly abundant 
and dense ECM, high interstitial pressure, chaotic 
vessel organization, enhanced solid stress are physical 
features that dramatically restrict the transport of 
cytotoxic therapeutic agents.7-9 Such physical barriers 
directly contribute to decreased therapeutic efficacy 
and the emergence of drug resistance by creating 
drug-free sanctuaries. This is particularly true in 
pancreatic ductal adenocarcinoma characterized by 
an intense desmoplastic reaction which regulates 
interstitial transport of drugs.10 Ablating the 
constituants of ECM with enzymatic and 
receptor-based means including collagenase, matrix 
metalloproteinases and angiotensin receptor blockers 
is part of the recent approaches being explored to 
render the tumor more profoundly vulnerable to 
chemotherapeutics and nanoparticles.10-15 
Alternatively, physical strategies using 
electromagnetic or acoustical waves [e.g., 
radiofrequency ablation, high-intensity focused 
ultrasound (HIFU) or magnetic and photothermal 
therapy (PTT)] are increasingly explored. Particularly, 
nanoparticles that can be activated on demand at a 
distance through external electromagnetic fields offer 
a more localized control of heating in tumor 
environment. Among photoactivable nanostructures, 
both plasmonic metallic nanoantennae (mostly gold 
particles) and carbon-based absorbing nanomaterials 
[e.g. carbon nanotubes (CNTs) and graphene oxide] 
have shown great promises for tumor treatment via 
localized heating when exposed to near-infrared 
(NIR) light.16 However, the multifaceted effects of 
nanoparticle-mediated hyperthermia on the tumor 
microenvironment remain elusive. Recent studies 
have mainly focused on the vascular barrier showing 
that local heating by nanoparticles could be exploited 
to increase the vascular permeability and 
spectacularly enhance the accumulation of molecular 
and nanosized (10-200 nm) agents into the tumor 
parenchyma.17 However, this effect could be 
tempered by the acquisition of a vascular 
thermotolerance upon reexposure to NIR, which 
represents an important adaptation of tumors to 
heat.18 Shifting the focus to the interstitial barriers, we 
recently demonstrated that mild hyperthermia 
generated by magnetic nanocubes under an 
alternating magnetic field had a local effect on the 
organization of collagen fibers that improved 
nanoparticle penetration in the tumor after repeated 
treatment and potentiate the delivery and efficacy of 
doxorubicin.19 Gold nanorods heated to ablative 
temperature (>50°C) also induced significant collagen 
remodeling.20 Hence, the ECM could be an important 
target of nanohyperthermia with still-underestimated 
effects on drug transport and normalization of tumor 
stiffness. Insight on how nanomaterial-mediated 
heating induces remodeling of ECM and how tumor 
stiffness might be modulated by hyperthermia would 
guide the development of oncologic approaches that 
use thermal energy generated at the nanoscale.  
Here, we explored the effects of local heating 
induced by multi-walled CNTs (MWCNTs) on 
epidermoid carcinoma microenvironment with the 
goal to relate the tumor stiffness evolution with tumor 
progression. Two conditions of heating were 
investigated by tuning NIR irradiation power: mild 
hyperthermia (43°C for 15 min) and thermal ablation 
(52°C for 3 min) representing thermal doses differing 
by three orders of magnitude.21 SWE imaging was 
used for real-time mapping of the tumor stiffness, 
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both during the two NIR irradiation sessions and over 
the days after the treatment, in parallel to the tumor 
volume monitoring. Ultrasound-based elastography 
was recently evaluated to monitor tumor stiffening 
associated to malignant progression and 
histopathological features.22-24 This non-invasive 
technique also proved useful for quantitative 
monitoring of thermal ablation by radiofrequency or 
HIFU in liver and heart25, 26 and to determine the 
elasticity threshold predictive of coagulation 
necrosis.27, 28 SWE was used in our study for the first 
time to get insight into nanothermotherapy effects on 
the tumor environment.  
Simultaneous monitoring of the tumor 
temperature by infrared imaging thermometry and of 
the tumor stiffness by SWE revealed a transient and 
reversible stiffening of the tumor tissue during laser 
irradiation, which was lowered at the second session 
of mild hyperthermia or photoablation. In contrast, 
over the days following PTT, the treated tumors 
exhibited a significant reduction of their stiffest area 
together with volume reduction, whereas non-treated 
tumors showed an increase of tumor stiffness which 
correlates with tumor growth. Such normalization of 
the tumor tissue elasticity is indicative of the response 
to PTT. At the microscopic level, the organization of 
the collagen matrix29 and the distribution of CNTs 
was assessed using two-photon excitation 
fluorescence microscopy (TPEF) and second harmonic 
generation microscopy (SHG) demonstrating a spatial 
correlation between the presence of the nanoheaters 
and the damages on collagen. Thus, we propose that 
CNT-induced thermal damages and subsequent 
remodeling of the tumor environment represent a 
promising adjuvant strategy to reverse tumor 
stiffening and normalize the tumor 
microenvironment.  
Results 
PTT was performed in mice bearing epidermoid 
carcinoma flank tumors after intratumoral 
administration of CNTs and exposition to 808 nm 
laser (Figure 1). Temperature monitoring indicated a 
step increase in the recorded tumor surface 
temperature as laser was turned on and an 
instantaneous drop as laser was turned off. The tumor 
temperature was increased to 52°C for 3 min for 
thermal ablation, and to 43°C for 15 min for mild 
hyperthermia treatment. During both treatments, the 
heart rate and, to a larger extent the respiratory rate, 
were slightly enhanced, as well as the rectal 
temperature (Supporting information Figure S1). In 
tumors non-injected with CNTs, unspecific heating of 
2°C and 1.4°C was observed keeping laser settings of 
thermal ablation and mild hyperthermia, respectively.  
 
 
Figure 1: Photothermal treatment mediated by CNTs. (a) Picture of a near-infrared irradiation (808 nm, 1 W/cm²) set-up in vivo with laser beam focusing on the tumor area. (b) 
Thermographic infrared pictures of a mouse under laser exposure during thermal ablation at four time points; right scale representing the color code for surface temperature. 
(c) Surface temperature plot as a function of the time for thermal ablation (T.A., in black – 3 min) and mild hyperthermia (M.H.T., in red – 15 min) and the related non-specific 
tissue heating for non-injected tumors for 3 min. 
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Figure 2: Real-time SWE mapping and quantification of tumor stiffness during thermal therapy. (a) Picture of the experimental set-up with near-infrared irradiation (IR) (808 nm, 
1-2 W/cm²) with simultaneous SWE in vivo. (b) Normalized mean tumor stiffness as a function of the time featuring laser exposure windows for mild hyperthermia group (n=6). 
(c) Normalized mean tumor stiffness plot as a function of the time featuring laser exposure windows for thermal ablation group (n=12). (d) Histogram illustrating the shift of the 
stiffness distribution for the tumor represented in (e), at three time points before, during and after the first irradiation of thermal ablation treatment (IR1). (e) SWE color stiffness 
mapping at three time points before, during and after the first irradiation of thermal ablation. (f) Histogram of the stiffness distribution of the same tumor before the first 
irradiation of the thermal ablation treatment (IR1) and before the second irradiation (IR2) showing the reversibility of laser-induced stiffening during IR1. (g) Histogram of the 
stiffness distribution for the control non-injected tumor represented in (h) at three time points before, during and after IR1 at the laser set-up corresponding to thermal ablation. 
(h) SWE color stiffness mapping at three time points for a control tumor before, during and after IR1. 
 
PTT Induces a Transient and Reversible 
Stiffening of Treated Tumors 
To evaluate the impact of CNT-mediated PTT on 
tumor stiffness during laser exposure time lapse, we 
performed SWE real-time monitoring (Figure 2). SWE 
mapping of tumor stiffness showed an acute effect 
during both thermal ablation and mild hyperthermia 
procedures. A transient and reversible stiffening of 
tumor tissue was observed for both, although thermal 
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ablation induced a more pronounced effect (50% 
increase in tumor stiffness versus 30% for mild 
hyperthermia). The stiffness continued to be 
monitored in the minutes following the treatment 
time lapse showing that it still increased. 
Interestingly, the tumor stiffness returned to its 
starting value 24 h after the first laser exposure for 
thermal ablation condition or even to a reduced level 
in the case of mild hyperthermia. PTT-induced tumor 
stiffening was also observed in the course of the 
second laser exposure, but to a lesser extent when 
compared to the first treatment (10% stiffness 
increment). There was no stiffness increment for 
control tumors non-injected with CNTs and irradiated 
at the laser set-up of thermal ablation or mild 
hyperthermia considering the time points before and 
after irradiation. 
PTT Inhibits Tumor Growth and Stabilizes 
Tumor Stiffness: Towards a Marker of 
Therapeutic Response 
Tumor growth was followed longitudinally by 
daily measurement of tumor dimensions (Figure 
3a-b). There was a steep rise in tumor growth for 
control animals with an almost 12-fold increase in 
tumor volume from days 0 to 10. Conversely, mild 
hyperthermia and thermal ablation inhibited tumor 
growth and induced tumor regression as tumor 
volume decreased by 2-fold considering equivalent 
time points. 
In addition to tumor growth, SWE was used for 
mapping and quantifying tumor stiffness at several 
time points (Figure 4a-c). Interestingly, tumor 
stiffness increased with time for control group while it 
remained stable for both thermal ablation and mild 
hyperthermia treated groups. As it can be visualized 
in SWE maps, tumor stiffening onset was observed for 
control at day 4 with the appearance of regions above 
30 kPa. These high stiffness zones were found to 
spread at day 6 extending nearly to the totality of the 
tumor at day 9. Stiffness remained constant within the 
tumor zone over time for treated groups. No 
significant difference was observed when comparing 
tumor stiffness for treated and control groups at day 2 
and day 4. However, tumor stiffness markedly 
differed for control and treated animals at days 6 
and 9.  
As a function of a tumor volume decrease or 
increase following thermal therapy, treated tumors 
were classified into responsive and non-responsive, 
respectively. The percentage of intratumoral area 
featuring very high rigidity (above 40 kPa) was 
compared for these two subsets as well as for control 
(Figure 4d). At an early time point (day 2), there was 
no significant difference between these three groups. 
However the percentage of intratumoral area 
featuring very high rigidity (above 40 kPa) decreased 
for the treatment-responsive group only, from day 6 
to 9. At day 9, this parameter was significantly 
different between the group responsive to treatment 
and the refractory one. It demonstrates that a 
reduction of the intratumoral area featuring very high 
rigidity was correlated to tumor regression. Therefore, 
this parameter may be considered as a marker of 
therapeutic outcome providing information on how 
tumors respond to thermal treatment. 
 
 
Figure 3: Photothermal therapy effect on tumor growth. (a) Tumor volume plot as a function of the time for control (n=14), mild hyperthermia (n=6) and thermal ablation 
(n=14) groups. Control group comprises non-CNT injected non-irradiated tumors (n=6) and non-CNT injected tumors irradiated with laser fluence used for mild hyperthermia 
(n=4) and thermal ablation (n=4). (b) Representative pictures of tumor growth evolution for control, mild hyperthermia and thermal ablation groups (The panel with the cross 
represents a sacrificed mouse whose tumor mass achieved ethical limit). 
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Figure 4: Evolution of the tumor stiffness following treatment. SWE color maps of stiffness (range 0-40 kPa) with corresponding B-mode view in the transverse plane of control 
(a) and treated (b) tumor over 9 days. Color scale is the same for all measurements and scale bar corresponds to 5 mm. The white arrow (D9, treated) indicates the location of 
the residual tumor. (c) Quantitative analysis of the normalized mean tumor stiffness for 9 days for control tumors (n=8) and CNT-injected tumors treated either by thermal 
ablation (n=12) or mild hyperthermia (n=6). The mean stiffness was normalized to the baseline value at day 0 before the first irradiation for each tumor (***p≤0.0004). (d) 
Quantitative analysis of the percentage of intratumoral area above the threshold of 40 kPa for three time points after treatment. Tumors treated by thermal ablation or mild 
hyperthermia were classified into treatment responsive (n=9) and non-responsive (n=7), as a function of the tumor volume decrease or increase following thermal therapy, 
respectively (**p=0.05 and ***p=0.002). 
 
PTT is Associated with Immune Cell 
Infiltration while Inducing Hemorrhagic 
Necrosis 
Histological HES or Masson's trichrome staining 
revealed that control tumors (CNT-injected but not 
laser irradiated and non-injected but irradiated) 
typically presented a necrotic core and a 
well-vascularized layer of viable tumor cells 
surrounded by a collagen-rich stroma (Figure S2 and 
Figure 5a-b). Histological analyses of tumor slices 
from PTT-treated groups evidenced extended necrosis 
(Figure 5c-g and Figure S3). Thermal ablation and 
mild hyperthermia induced an immediate impact on 
tumor tissue as hemorrhagic necrosis was observed at 
1h time point (Figure 5c-g). Both thermal treatments 
were found to extend necrosis into tumor tissues and 
inflammatory infiltration was often observed in the 
necrotic tissue. CNTs were evidenced as black spots 
(Figure 5a-b-c-e). They were visualized embedded 
into necrosis zones associated with immune cell 
infiltration for PTT-treated tumors or in viable cell 
layers of injected non-irradiated tumors. CNTs were 
also observed in the collagen-rich ECM of treated 
tumors or of injected non-irradiated tumors (Figure S3 
and Figure 5a-b). At the microscopic level, TEM 
observations of CNT-injected non irradiated tumors 
showed disseminated CNTs along collagen fibrils as 
well as CNT aggregates in the extracellular space 
(Figure S4). Following thermal ablation (Figure S5) 
and mild hyperthermia (Figure S6), CNT aggregates 
were surrounded by highly damaged ECM and cells, 
while collagen matrix distant from CNTs remained 
intact. 
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Figure 5: Histological analysis of CNT-injected non-irradiated control, thermal ablation and mild hyperthermia groups. Control group of CNT-injected non-irradiated tumor 
(a-b). High magnification view of tumor cell mass featured carbon nanotubes among tumor cells (a). Carbon nanotubes were visualized as dark spots near collagen fibers (left 
white arrows) and in the tumor mass featuring inflammatory cells (center and right white arrows) (b). Tumor 1 h following thermal ablation (c-d) featuring an extended necrotic 
zone (red arrow) including hemorrhagic necrosis (blue arrow) (c). Necrotic tissue at higher magnification (d). Tumor 2 days following thermal ablation featuring an extended 
necrotic zone (red arrow) including hemorrhagic necrosis (blue arrow) with a zone featuring a large amount of carbon nanotubes (white star) (e). Tumor 1 h following mild 
hyperthermia (f-g) featuring an extended necrotic zone (red arrow) including hemorrhagic necrosis (blue arrow) (f). Hemorrhagic necrotic tissue (blue arrow) at higher 
magnification (g). 
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PTT Induces Collagen Destructuration in the 
Tumor Site 
PTT effect on tumor stiffness may be related to 
the cytotoxic action on cells reducing cell density in 
the tumor mass, but also on the ECM. Thus SHG 
microscopy was used to image collagen fibers as well 
as CNTs ex vivo using optical conditions preserving 
the integrity of the analyzed sample slices (Figure S7). 
Tuning the pulsed laser at 810 nm allowed imaging 
type I and III collagen fibers through SHG as well as 
CNTs owing to their two-photon cross-section 
absorption in the entire visible spectrum. In contrast, 
by changing the excitation to 850 nm wavelength, 
only CNTs were detected. The signal of collagen 
fibers was thus isolated by subtracting 850 nm and 
810 nm images. 
Intact collagen fibers were observed for control 
tumors. For the injected groups, CNTs were also 
visualized as bright spots both at 810 and 850 nm 
excitation and nearby intact collagen fibers at 810 nm. 
However, collagen fibers were not visualized nearby 
CNTs of injected and irradiated tumors at 30-min and 
1 day post-irradiation, indicating that CNT-mediated 
PTT could act on tumor ECM and induce 
destructuration of collagen fibers (Figure 6a).  
In order to quantitatively appraise the 
co-localization of CNTs and of collagen 
destructuration, a Pearson's correlation coefficient 
was calculated considering the same region of interest 
from images acquired at 810 and 850 nm (Figure 6b). 
Collagen fibers being destructurated, the detected 
image at 810 nm matched the one at 850 nm for 
CNT-injected irradiated groups. Indeed Pearson’s 
correlation coefficient was significantly different 
following thermal ablation and mild hyperthermia at 
30 min and 1 day time points (Pearson’s coefficient of 
about 0.8) compared to CNT-injected non-irradiated 
control tumors (0.5). 
PTT-induced cell damages were also evaluated 
in tumor slices by TPEF microscopy (Figure 7). 
Without laser irradiation, the tissue preserved its 
integrity both in the presence or absence of CNTs. 
Following laser exposure, tissue damage was 
observed exclusively in the presence of CNTs, the 
zones devoid of CNTs preserving their integrity. As 
represented in Figure 7 c-d, a left-shift of the 
distribution of cell autofluorescence levels was 
observed following PTT indicating tissue damage in 
comparison to all three control conditions. A 
statistically significant nearly 2-fold decrease in the 
average autofluorescence cell signal was induced by 
PTT indicating extended cell damage.  
Second Harmonic Generation to Induce and 
Image In Situ CNT-mediated PPT Damages in 
Real Time  
For the above tissue analyses, TPEF/SHG laser 
exposure parameters were set in order to enable 
image acquisition without inducing artefactual 
destructuration of collagen and tissue destruction 
during analysis. In a different approach aiming to 
investigate in real time the CNT-induced PTT effects 
on tissue integrity at the microscopic level, we 
deliberately shifted to a regimen imputing a higher 
laser power into tissue slices and exciting the CNTs 
present in the analyzed tissue. We thus conceived 
simultaneous PTT and dual CNT/collagen imaging 
under SHG in real time. For this in situ experiment, 
CNTs were first injected in fresh sheep tendon, used 
as a model type 1 collagen-rich tissue. Experiments 
were also conducted on tumor tissue slices.  
Figure S7 shows that CNT excitation upon 810 
nm laser exposure at 40 mW induced an immediate 
and complete destruction of surrounding collagen 
fibers both in sheep tendon and tumor tissue. Indeed, 
collagen fibers initially colocalized with CNTs were 
no more detected after excitation when imaged with 
standard acquisition condition. Conversely, collagen 
fibers remained intact after excitation under the same 
conditions in zones devoid of CNTs. This evidenced 
that CNT-mediated PTT was indeed able to locally 
damage ECM via the destructuration of collagen 
fibers, confirming a causality effect. In addition to 
collagen denaturation, cell damage observed as dark 
areas in TPEF autofluorescence imaging was 
evidenced only in the presence of CNTs and following 
excitation. Conversely no cell damage was observed 
in the presence of CNTs under standard acquisition 
settings, confirming real-time cell destruction in 
response to CNT-mediated PTT.  
Discussion 
In the context of thermal treatment of tumors, 
the prediction of the multiscale heat-induced effects 
remains challenging. Particularly, the use of remotely 
activated nanomediators for local hyperthermia has 
been documented with focus on tumor growth and 
vascular effects, but much less is known on the 
remodeling effect on the tumor microenvironment. 
The present study aimed (1) to quantify in real time 
the changes of elasticity in epidermoid tumor during, 
and shortly after, two sessions of laser irradiation, (2) 
to follow-up elasticity variation and tumor growth 
ensuing the treatment, (3) to compare mild 
hyperthermia and photoablative treatment regimens, 
and (4) to characterize the direct damages of 
irradiated CNTs on ECM and cells.  
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Figure 6: Collagen destructuration analysis by SHG in tumor slices in response to CNT-mediated PTT (a) Images of only collagen fibers were obtained by substracting the 850 
nm excitation images to 810 nm ones. Images of only CNTs were acquired at 850 nm excitation wavelength. Images of both collagen and CNTs were obtained at 810 nm 
excitation wavelength. Intact collagen fibers were observed for the non CNT-injected non-irradiated control, the non CNT-injected irradiated control as well as for the 
CNT-injected non-irradiated control (first, second and third lines). For the latter, CNTs were visualized as bright spots (third line). For the CNT-injected and irradiated group 
(thermal ablation condition, 1 day time point in the fourth line), few intact collagen fibers were observed in zones devoid of CNTs while destructurated collagen fibers were 
visualized nearby CNTs (circled region). (b) Pearson’s coefficient demonstrating the correlation between CNTs and collagen destructuration (n=12 slices from 3 different tumors 
for each condition, TA (MH) 1D: thermal ablation (respectively, mild hyperthermia) at day 1 post-irradiation, TA (MH) 30 min: thermal ablation (respectively, mild hyperthermia) 
30 min post-irradiation). 
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Figure 7: Cell damage evaluation by TPEF and SHG microscopy in response to CNT-mediated PTT in tumor slices. Each image is a reconstitution of 6×5 stitched pictures viewed 
in volume with the software Imaris BitPlan (8 steps of 15 µm). Circled regions indicate the presence of CNTs. Without laser irradiation, the integrity of the tissue was observed 
both in the presence or absence of CNTs (a) for CNT-injected non-irradiated control group. Under laser exposure, tissue damage correlated with the presence of CNTs while 
the tissue preserved its integrity in the regions devoid of CNTs for CNT-injected and irradiated group (b). Distribution of cell autofluorescence levels in TPEF images of tumor 
slices from non CNT-injected non-irradiated and CNT-injected non-irradiated conditions (c) as well as non CNT-injected irradiated and CNT-injected irradiated (thermal 
ablation at day 1) conditions (d). A left-shift of cell autofluorescence levels was observed following PTT indicating cell damage in comparison to all three control conditions. 
Average intensity of cell autofluorescence in TPEF images of tumor slices from non CNT-injected non-irradiated; CNT-injected non-irradiated conditions; non CNT-injected 
irradiated and CNT-injected irradiated (thermal ablation at day 1) conditions (e). A statistically significant nearly 2-fold decrease in cell signal was induced by photothermal 
treatment indicating cell damage (n=12 slices from 3 different tumors for each condition). 
 
Previous studies have illustrated the role of heat 
stress mediated by photoresponsive nanoparticles on 
cell viability, cell metabolism, thermally activated 
drug delivery and radio- and chemosensitization at 
the cellular level.30-33 However, regardless of the 
administration route, most nanoparticles do not attain 
the neoplastic cells because they are blocked in their 
diffusion or convection by disorganized blood and 
lymphatic vascular network, dense fibrous matrix, 
and off-target uptake by immune cells.13, 34, 35 
Consequently, the tumor stroma represents a new 
target for tumor treatment.36 Nanohyperthermia was 
demonstrated to improve drug transport and tumor 
accumulation due to an increase of blood flow and 
interstitial extravasation.17, 18 It is now well 
appreciated that the dense collagen matrix of tumor 
ECM also dramatically reduces the penetration and 
efficacy of drugs and nanotherapeutics.13, 29 Losartan, 
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a clinically approved angiotensin II receptor 
antagonist was shown to inhibit collagen I production 
and improve drug/nanoparticle diffusion into 
tumors.11 Other strategies proposed anti-ECM 
antibody to target collagen and achieve sustained 
release of proteins in the collagen network.37 
Regarding nanoparticle-based therapy, magnetic 
nanocubes were found embedded along the collagen 
fibers of epidermoid A431 tumor tissue eliciting 
structural change of the collagen network upon local 
heating, which favored further penetration of the 
nanoparticles and drug.19 Gold nanorods 
accumulated near collagen fibrils in vitro were shown 
to denaturate the quarternary structure of collagen in 
response to NIR irradiation.20,29 In the present work, 
we have demonstrated the local ablation of collagen 
fibers colocalizing with CNTs irradiated with NIR 
light. TPEF/SHG microscopies were successful in 
localizing both the collagen fibers and CNTs. In sheep 
tendon injected with CNTs, in situ laser scanning 
under the microscope induced thermal ablation of 
collagen (assessed by the disappearence of SHG signal 
related to collagen fibrils) exclusively in the region 
where CNTs were present. Adjacent CNT-free region 
showed intact collagen fibrils after laser scanning. The 
spatial selectivity of photothermal ablation of collagen 
could be estimated to a distance of about 10 µm 
around the CNT-rich zone. Similar laser scanning on 
tumor slices ex vivo allowed to demonstrate the 
selective denaturation of both the collagen and the 
cellularized tissue in the region of CNT accumulation. 
Due to highly efficient light-to-heat conversion by 
CNTs, collagen fibers gain enough energy to 
experience an irreversible transformation from an 
helical-ordered state to a random like structure, 
subsequently loosing their SHG signal, and cellular 
stuctures (including the neoplastic cells) are 
simultaneously ablated. Such real-time and in situ 
observations of CNT-dependent irradiation damages 
helped us to interpret the histological pattern of the 
different groups of tumors before and after treatment. 
In particular, the laser-induced destructuration of 
ECM and hemorrhagic necrosis were spatially 
correlated with the distribution of CNTs in the treated 
groups without differences between mild 
hyperthermia and thermal ablation conditions. 
As the elastic properties of biological tissues are 
related to structural organizations at the molecular, 
cellular and tissular levels, tissue stiffness is expected 
to vary with thermal damages and protein 
denaturation.38 
In this study, we took advantage of the real-time 
and quantitative capabilities of SWE to investigate for 
the first time the relationship between in vivo stiffness 
changes and temperature-controlled nanohyper-
thermia treatments. Despite the large heterogeneity of 
the stiffness pattern between the different tumors, the 
normalization of the mean stiffness value by its 
baseline value before the treatment enabled to 
provide statistically significant evolution over time 
during and after treatment. Significant differences 
were also evidenced between the treated and 
non-treated groups.  
Importantly, stiffness monitoring revealed a 
two-stage process with contrasted evolution 
differentiating the acute response to the laser 
irradiation and the delayed effects on the days 
post-treatment. During the course of laser treatment 
and in the following 15 min cooling phase, a nearly 
two-fold increase of the tumor stiffness was observed 
both for mild hyperthermia and thermal ablation 
(+60% versus +75%, respectively). Interestingly, the 
stiffness was still increasing during the cooling phase, 
in line with a previous work using MR elastography 
to follow laser ablation of hepatic tumors.39 This 
suggested that the tissue underwent a photo-induced 
denaturation process. However, more surprinsingly, 
the stiffness retrieved its initial value or a slightly 
lower value (-20%) on the day after the first treatment 
of thermal ablation and mild hyperthermia, 
respectively. The second treatment on day 2 induced a 
much lower stiffness increase in comparison to the 
first treatment (<+20%). The temporal reversibility of 
the photo-induced stiffness enhancement in the tumor 
is an important unexpected result in comparison to 
previous works aiming to characterize the thermal 
dependence of tissue stiffness. These studies 
determined a well-defined starting point of stiffening 
in muscle ex vivo and in vivo with a sharp slope 
rupture for temperature above 57°C and this change 
was particularly useful for non-invasive assessment of 
the spatial extention of thermal-induced necrotic 
lesions.27, 28 For example, HIFU and radiofrequency 
ablated regions exhibited three to four times stiffer 
value in the post-treatment lesions, attributed to 
protein denaturation and tissue coagulative 
necrosis.25, 26 However, the delayed response of the 
tissue mechanics to the thermal treatment was not 
explored. Here, we have shown a clear reversion of 
the acute heat-induced stiffening one day after the 
treatment. Moreover, a second hyperthermia 
treatment was not able to induce acute stiffening. 
Additionally the tumor stiffness tends to diminish 
over days after treatment in parallel to the tumor 
volume regression. These findings indicate a dynamic 
remodeling of the tumor tissue, which slackens 
following thermal ablation of ECM and cell 
structures. This second phase of tissue response 
corresponds to a diminution of the stiffest areas of the 
tumor, in contrast to the non-treated tumors which 
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show a stiffness enhancement. Moreover, the change 
of tumor stiffness correlates with tumor volume 
evolution parallely in treated and untreated tumors. 
Modification of tumor elasticity and heterogeneity 
was correlated with response to treatment. In good 
responders, elasticity and elasticity heterogeneity 
diminished. This suggests that the tumor elasticity 
evolution, non-invasively assessed by SWE, could be 
a prognosis marker of the tumor response to the 
photothermal treatment. The nanoparticle-mediated 
thermal damages deeply remodel the tumor 
microenvironment and consistently achieve objective 
tumor responses. 
Another stricking results is that similar patterns 
of reversible stiffening (acute response) and delayed 
softening (delayed response) were found for mild 
hyperthermia and photoablation (although the short 
term kinetics were expectedly different). This result is 
in apparent contradiction with the concept of thermal 
dose established by Sapareto and Dewey to assess 
time-temperature dependent 50% necrosis on cells.21 
Cumulative equivalent minutes at 43°C (CEM43) is 
the accepted metric for thermal dose assessment that 
correlates well with the severity of thermal damage in 
a variety of tissues.40 Moreover, a relationship 
between the thermal dose and the tissue stiffness 
evolution was also found.28 Here, the thermal dose 
estimated from temperature measurement at the 
surface of the tumor, differed by three orders of 
magnitude between mild hyperthermia and 
photoablation conditions, but yet the elasticity 
variations in the tumor tissue were similar. This 
suggests that the apparent thermal dose is not 
appropriate to assess the effects of heat produced 
locally and from the inside by the accumulated CNTs, 
which may attain much higher temperatures at the 
microscopic scale. We can conclude from the similar 
effect of the mild hyperthermia and photoablation on 
the tumor stiffness and regression, that the energy 
deposition at the microscopic level of the mild 
hyperthermia condition is sufficient to achieve tumor 
response while diminishing off-target heat effects. 
This effect could be easily achieved even when lower 
dose of nanoheaters could penetrate the tumor after 
an intravenous injection. Here intratumoral 
administration of MWCNTs was prefered in order to 
modulate the heating regime by use of laser power 
and compare mild hyperthermia with thermal 
ablation. 
In conclusion, photothermal therapy mediated 
by CNTs was found to normalize the aberrant 
stiffening of the tumor stroma, which is associated to 
tumor progression. Through a local denaturation of 
adjacent tissue and particularly on collagen fibers, 
nanomaterial-generated heat stress induce a 
remodeling and softening of the tumor 
microenvironment concomitant to tumor regression. 
SWE elastography imaging proved useful for tracking 
spatio-temporal biomechanical changes that occurred 
during nanoparticle-mediated hyperthermia and 
along the response of the tumor to the treatment. As 
the stiffening of the ECM is implicated in malignant 
transformation and also drives tumor invasion and 
metastasis, tumor softening could also represent a 
mechanical cue for tumor regression. Furthermore 
nanoparticle-induced ablation of the ECM physical 
barrier that currently limits the delivery of 
chemotherapeutics has the potential to enhance the 
efficacy of current treatments. 
Materials and methods 
Animal model and cell lines. All animal 
experiments were performed in agreement with 
institutional animal use and care regulations after 
approval by the local Ethics Committee. 
Eight-week-old female nude NMRI mice (40 animals 
provided by Janvier, France and weighing 30 ± 2 g) 
were housed in polypropylene cages and were 
provided with food and water ad libitum. The animals 
were allowed to acclimate to the facility for at least 
one week before being used in the experiments. 
A431 human epidermoid carcinoma cells were 
cultured as adherent cells in complete RPMI culture 
medium supplemented with 10% (v/v) fetal bovine 
serum and 100 U/mL penicillin streptomycin at 37°C 
in 5% CO2.  
Each mouse was subcutaneously injected on 
both flanks with 1.5×106 A431 cells resuspended in a 
volume of 100 µL of physiological saline per 
inoculum. When the tumor volume attained 60-70 
mm3 (about 20 days after the injection of A431 cells), 
tumors were considered ready for treatment. 
Throughout the experiment, tumor volumes were 
measured on a daily basis and calculated from the 
formula V=(D×d2)/2, where D is the longest diameter 
and d the diameter perpendicular to D.  
Photothermal therapy and temperature monitoring. 
Multi-walled CNTs (95% purity; batch 1240XH, 20-30 
nm diameter, 0.5-2 μm length) were purchased from 
Nanostructured and Amorphous Materials. To 
shorten the nanotubes and increase their water 
dispersibility, MWCNTs were first oxidized using a 
mixture of sulfuric acid and nitric acid in a water bath 
sonicator. Following this acidic treatment, the length 
of the nanotubes was reduced to ~ 400 nm. This 
treatment also introduced COOH groups, that are 
essential for high dispersibility, low toxicity, high 
cellular uptake, intravenous injectability and 
favorable pharmacokinetics for medical use as 
demonstrated earlier.41 CNTs were sonicated for 10 
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min and dispersed in physiological saline at a 
concentration of 500 µg/mL. Electron microscopy 
characterization and determination of photothermal 
conversion efficiency of shortened and carboxylated 
MWCNTs have been detailed previously in 
reference 33. 
During all PTT protocol steps, the mice were 
anesthetized with 2% isoflurane supplied in air 
mixture. The mice were first intratumorally injected 
with 50 µL of CNT suspension (500 µg/mL). About 5 
min after injection, tumors were irradiated using a 808 
nm diode laser featuring a fiber delivery system. The 
optical fiber was fixed so that the laser spot focused 
precisely on the tumor site. Two modalities of 
treatment were tested: the thermal ablation and the 
mild hyperthermia. The duration of treatment and the 
tumor temperature were 3 min at 52°C for thermal 
ablation and 15 min at 43°C for mild hyperthermia, 
respectively (corresponding to a laser output power at 
0.3 W/cm2 and 1 W/cm2, respectively). The treatment 
was performed twice within an interval of 24 h. The 
time of the first treatment was considered time 0. The 
surface temperature on the mouse skin was mapped 
and monitored by a FLIR SC7000 infrared camera. All 
the acquisitions were processed by Altair software 
(FLIR Systems, Inc.).  
Physiological parameters were acquired using 
the imaging station of the VEVO770 (Visualsonics, 
Toronto, Canada). This ultrasound device displays the 
physiological information gathered by the THM150 
system (Indus Instruments, Houston, Texas, USA). 
Briefly, the animal under isoflurane anesthesia was 
positionned on the THM 150 heating pad, ECG 
contact Gel was applied on paws and each paw was 
maintained in contact with each electrode using 
adhesive. Body temperature was monitored using a 
rectal probe, enabling active control of the heating 
pad as well. 
Shear wave elastography. Ultrasound tumor 
measurements were performed during laser 
irradiation and every 2 days during the entire 
follow-up of the tumor growth. Images were acquired 
with the ultrasound device Aixplorer (SuperSonic 
Imagine, Aix-en-Provence, France) using a 15-MHz 
superficial probe dedicated to research (256 elements, 
0.125 µm pitch). During the measurements, the mice 
were anesthetized under isoflurane and their body 
temperature was maintained at physiological level 
using a heating plate. The tumors were covered with a 
layer of standard ultrasound gel before measurement. 
B-mode images were first acquired in order to 
delineate manually the region of interest (ROI) 
corresponding to the tumor contours. Secondly, SWE 
mode was performed using the penetration mode 
with a color scale ranging from 0 (transparent) to 40 
kPa (red), arbitrarily chosen in the beginning of the 
study according to the expected stiffness values. The 
area, the diameter and a set of stiffness values (mean, 
minimum, maximum and standard deviation) were 
recorded for (i) the ROI as previously defined, and (ii) 
a subset region corresponding to the ROI saturated 
area (>40 kPa).  
Histology. The tumors were excised and fixed in 
pH 7.4 phosphate-buffered 10% formalin. The tumors 
were dehydrated in graded solutions of ethanol and 
embedded in paraffin. Five micrometer tissue sections 
were stained by hematoxylin / eosin / Saffron (HES) 
and Masson’s trichrome stain. 
Transmission electron microscopy. The tumors were 
cut into 1 mm3 pieces after excision and fixed with 2% 
glutaraldehyde in 0.1 M sodium cacodylate buffer, 
postfixed with 1% osmium tetroxide containing 1.5% 
potassium cyanoferrate, gradually dehydrated in 
ethanol, and embedded in Epon. Thin sections (70 
nm) of selected zones were observed with Zeiss 
EM902 electron microscope operated at 80 keV 
(platform MIMA2, INRA, Jouy-en-Josas, France).  
Two-photon-excited fluorescence and second 
harmonic generation microscopy. The images were 
obtained using an inverted stand Leica SP5 
microscope (Leica Microsystems GmbH, Wetzlar, 
Germany) coupled to a femtosecond Ti:sapphire laser 
(Chameleon, Coherent, Saclay, France) tuned at a 
wavelength of 810 or 850 nm for all experiments. The 
laser beam was circularly polarized and a Leica 
Microsystems HCX IRAPO 25×/0.95 W objective was 
used. Second harmonic generation (SHG – collagen 
structures and CNTs) and two-photon-excited 
fluorescence (TPEF – autofluorescence and CNTs) 
signals were detected in epi-collection through a 
405/15 and a 525/50 nm bandpass filters respectively, 
by NDD PMT detectors (Leica Microsystems) with a 
constant voltage supply, at constant laser excitation 
power, allowing direct comparison of TPEF and SHG 
intensity values. Isolated CNT signal was detected 
through the same filter with a 850 nm tuned laser to 
avoid the detection of second harmonic signal, with 
an increase of the laser power of 3% to offset the loss 
of power due to the wavelength change. 
We first checked if the image acquisitions could 
be performed without damaging the analyzed tissue. 
In fact, SHG is a nonlinear imaging technique, as it 
uses a pulsed laser source with a very high peak 
power. Therefore, tissue destruction may be induced 
by the interaction between the pulsed laser and the 
CNTs present in the analyzed tissue depending on the 
set-up. For imaging purpose, standard acquisition 
conditions were 810 nm tuned pulsed laser, 20 mW at 
the exit of the 25× objective, NA0.95, W, Leica. This 
set-up induced no damage to tissues, even after 10 
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successive scans of the same region of interest in the 
presence or not of CNTs in the analyzed tissue.  
In a different approach, we intentionally took 
advantage of the pulsed laser SHG microscopy to 
irradiate the CNTs present in the analyzed tissue in 
order to perform real-time PTT. For this purpose, the 
set-up was 810 nm laser exposures at 40 mW zoomed 
18 times during 20 s.  
Statistics. Data are presented as standard 
deviation from the mean or as standard error of the 
mean. The statistical significance of the differences 
between groups was assessed with the 
Mann-Whitney U Test using Xlstat software 2008 
(Addinsoft, Paris, France). A minimum of 95% 
confidence level was considered significant.  
Supplementary Material  
Supplementary figures.  
http://www.thno.org/v07p0329s1.pdf   
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